Woman gives birth to triplets in underground Israeli hospital
A woman gave birth to triplets Monday in Israel's Rambam hospital, one of several in the country that have moved some operations underground as Iranian strikes hit the city of Haifa this week, according to Reuters.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
Iranians saw America as better friend than Russia before war: Official
(NewsNation) — Iran's Health Ministry spokesman told NewsNation that Iranians viewed America as a better friend than Russia before President Donald Trump backed Israel's attacks. 'There was no perception about America prior to this. Some didn't like America, some had no opinion, and some considered America a better friend than Russia,' spokesman Hossein Kermanpour in an interview with NewsNation. A week into their war, Israel and Iran exchanged more strikes Friday as new diplomatic efforts led by the Europeans took place in Geneva. Kermanpour said Iranians were 'very surprised' by Trump and European support for the Israeli operation, adding that it confirmed suspicions that 'America is not to be trusted.' He said the strikes came 'in the midst of fruitful negotiations.' Iran nuclear weapons claims: What we know and what we don't However, he said that Iranians do not support U.S. involvement in the conflict with Israel following the recent strikes. Iran's Health Ministry reported more than 3,000 people injured in Israeli strikes, with 90% being civilians, and about 400 killed, according to Kermanpour. Kermanpour said about 2,000 of the injured have been treated and discharged. The casualties include a 2-month-old baby who was killed and a 4-year-old boy among the wounded, making them the youngest victims and injured, respectively. The Health Ministry spokesman said the attacks occurred 'while the people were sleeping' and targeted 'more than ten provinces of the country, including Tehran,' killing what he described as 'a significant number of civilians and military,' calling them 'martyrs.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
14 hours ago
- Yahoo
Muscle-preserving drugs could generate over $30 billion in sales by 2035, TD Cowen says
By Bhanvi Satija (Reuters) -Treatments designed to help patients preserve muscle while losing weight with popular obesity drugs by Eli Lilly and Novo Nordisk could generate more than $30 billion in sales by 2035, analysts at TD Cowen said on Friday. About a dozen companies are racing to develop such therapies, most of which are being tested in combination with Lilly's Zepbound or Novo's Wegovy, both of which target the GLP-1 protein to help control appetite. The initial Wall Street estimates for muscle-preserving therapies follow promising mid-stage results from experimental drugs developed by Regeneron and Scholar Rock. Investors are closely watching mid-stage data from Lilly's muscle mass-preserving drug, bimagrumab, which is scheduled for presentation at a medical conference next week. Analysts have projected that obesity drugs sales could reach $150 billion a year by the early 2030s. The unmet need to preserve muscle will grow with the use of GLP-1 drugs for obesity, said TD Cowen analyst Tyler Van Buren. Doctors have raised concerns that patients may experience a decrease in overall strength due to muscle loss associated with Zepbound and Wegovy, while experts suggest that more muscle can help patients maintain long-term weight loss. Van Buren said that the first such treatment could launch by 2028, although regulatory challenges remain because these treatments must demonstrate additional health benefits to secure approval. "We believe quality of weight loss and lean mass preservation ... is far too important for long-term health outcomes to be ignored and that this will be figured out," Van Buren said. Some of the new drugs target the myostatin protein, which is associated with muscle growth, and are expected to see broader use due to their superior safety profile, capturing the majority of the market share, Van Buren said. Other drugs target activin, a protein with multiple biological functions. Van Buren said that activin-based drugs will be reserved for patients at higher risk of losing strength, forecasting sales of about $5 billion by 2035. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNN
19 hours ago
- CNN
CNN visits underground hospital in Israel treating patients from Iranian missile attacks
As Iran and Israel trade missile attacks, Israeli hospitals are moving operations underground. CNN's Clarissa Ward visits Ichilov hospital in Tel Aviv to see how doctors prep for incoming attacks.
